Viking Therapeutics (NASDAQ: VKTX) Stock Soars on Upbeat Phase 2 Results from Obesity Clinical Trial
Viking Therapeutics (NASDAQ: VKTX) stock skyrocketed following the release of promising Phase 2 data from its obesity study. Viking Therapeutics […]
Viking Therapeutics